B cell

(redirected from B-cell)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to B-cell: B-cell lymphoma

B cell

[′bē ‚sel]
(immunology)
One of a heterogeneous population of bone-marrow-derived lymphocytes which participates in the immune responses. Also known as B lymphocyte.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Gray Zone Lymphoma: Better Treated Like Hodgkin Lymphoma or Mediastinal Large B-Cell Lymphoma?
(22,24) Finally, false-positive results can occur when a B-cell population emerges as a dominant clone in RLH.
A retrospective analysis was performed on 106 patients who were diagnosed with CD20-positive B-cell non-Hodgkin's lymphoma according to the World Health Organization classification for pathological diagnosis, between January 2010 and April 2017; these patients were administered rituximab-containing chemotherapy, and they completed the follow-up (19).
B-cell epitope prediction aims to facilitate B-cell epitope identification with the practical purpose of replacing the antigen for antibody production or for carrying structurefunction studies.
Kymriah became the first CAR-T cell therapy to receive regulatory approval when it was approved by the FDA in August 2017 for the treatment of patients up to 25 years of age with B-cell precursor ALL that is refractory or in second or later relapse.
Immunohistochemically, IVLBCL is positive for B-cell markers with variable aberrant expression of CD5.
Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.
Results: We found that miR-155 expression levels differentiate lymphoma entities from normal subjects (p [less than or equal to] 0.001) and its expression fold changes distinguish B-cell lymphoma subtypes from each other's (p<0.05).
Keywords: Chronic lymphocytic leukemia, familial form, monoclonal B-cell lymphocytosis
Treatment of B-cell NHL typically relies upon multiagent cytotoxic chemotherapy (e.g., cyclophosphamide, doxorubicin, vincristine, and prednisone [CHOP]), tailored to the specific subtype of NHL and certain patient characteristics.